Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery

Artificial Cells, Nanomedicine and Biotechnology

Volumn 42, Issue 3, 2014, Pages 205-209

  Chen, Daquan ^a   Yu, Hongyun ^a   Mu, Hongjie ^a,b   Li, Guisheng ^a,b   Shen, Yan ^c  

^a YANTAI UNIVERSITY   (China)

^b State Key Laboratory of Long acting Targeting Drug Delivery System   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Double pH sensitive; Ginsenoside Rh2 delivery; Mixed micelles; Multicore niosomes

Indexed keywords

DRUG DELIVERY; ENCAPSULATION;

ANTI-TUMOR EFFICACY; AQUEOUS MEDIUM; ENCAPSULATION EFFICIENCY; GINSENOSIDES; MIXED MICELLES; NIOSOMES; PH SENSITIVE; PLURONIC F-68;

MICELLES;

GINSENOSIDE RH 2; MACROGOL 2000; NIOSOME; POLOXAMER; ANTINEOPLASTIC AGENT; GINSENOSIDE; LIPOSOME; MICELLE; POLYMER;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STABILITY; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG RELEASE; DRUG SCREENING; MCF 7 CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG LIBERATION; DRUG STABILITY; GINSENOSIDES; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MCF-7 CELLS; MICE; MICELLES; POLYMERS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901046803     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2013.794358     Document Type: Article

References (21)

1. An IS, An S, Kwon KJ, Kim YJ, Bae S. 2013. Ginsenoside Rh2 mediates changes in the microRNA expression profi le of human non-small cell lung cancer A549 cells. Oncol Rep. 29: 523-528.
2. Chen D, Jiang X, Huang Y, Zhang C, Ping Q. 2010a. pH-Sensitive mPEGHz- cholesterol conjugates as a liposome delivery system. J Bioact Compat Polym. 25: 527-542.
3. Chen D, Jiang X, Liu J, Jin X, Zhang C, Ping Q. 2010b. In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, effi cacy assessment. Artif Cells Blood Substit Immobil Biotechnol. 38: 136-142.
4. Chen D, Liu W, Shen Y, Mu H, Zhang Y, Liang R, et al. 2011. Eff ects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomedicine. 6: 2053-2061.
5. Chen D, Sun K, Mu H, Tang M, Liang R, Wang A, et al. 2012. pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomedicine. 7, 2621-2030.
6. Chung KS, Cho SH, Shin JS, Kim DH, Choi JH, Choi SY, et al. 2012. Ginsenoside Rh2 induces cell cycle arrest and diff erentiation in human leukemia cells by upregulating TGF- expression. Carcinogenesis. 34: 331-340.
7. Fiore VF, Lofton MC, Roser-Page S, Yang SC, Roman J, Murthy N, Barker TH. 2010. Polyketal microparticles for therapeutic delivery to the lung. Biomaterials. 31: 810-817.
8. Heff ernan M, Murthy N. 2005. Polyketal nanoparticles: a new pHsensitive biodegradable drug delivery vehicle. Bioconjug Chem. 16: 1340-1342.
9. Heff ernan MJ, Kasturi SP, Yang SC, Pulendran B, Murthy N. 2009. Th e stimulation of CD8 - T cells by dendritic cells pulsed withpolyketal microparticles containing ion-paired protein antigenand poly(inosinic acid)-poly(cytidylic acid). Biomaterials. 30: 910-918.
10. Heller J, Barr J. 2004. Poly(ortho esters)-from concept to reality. Biomacromolecules. 5: 1625-1632.
11. Lee S, Yang SC, Heff ernan MJ, Taylor WR, Murthy N. 2007. Polyketal Microparticles: A New Delivery Vehicle for Superoxide Dismutase. Bioconjugate Chem. 18: 4-7.
12. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. 2011. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 301: 185-192.
13. Park EK, Lee EJ, Lee SH, Koo KH, Sung JY, Hwang EH, et al. 2010. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt. Br J Pharmacol. 160: 1212-1223.
14. Siepmann J, G öpferich A. 2001. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev. 48: 229-247.
15. Tomlinson R, Heller J, Brocchini S, Duncan R. 2003. Polyacetaldoxorubicin conjugates designed for pH-dependent degradation. Bioconjugate Chem. 14: 1096-1106.
16. von Burkersroda F, Schedl L, G öpferich A. 2002. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 23: 4221-4231.
17. Wang C, Ge Q, Ting D, Nguyen D, Shen HR, Chen J, et al. 2004. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater. 3: 190-196.
18. Wang H, Yu P, Gou H, Zhang J, Zhu M, Wang ZH, et al. 2012. Cardioprotective eff ects of 20(S)-Ginsenoside Rh2 against doxorubicininduced cardiotoxicity in vitro and in vivo. Evid Based Complement Alternat Med. 2012: 506214
19. Yuk SH, Oh KS, Koo H, Jeon H, Kim K, Kwon IC. 2011. Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs. Biomaterials. 32: 7924-7931.
20. Zhang CY, Yang YQ, Huang TX, Zhao B, Guo XD, Wang JF, Zhang LJ. 2012. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials. 33: 6273-6283.
21. Zhang J, Zhou F, Wu X, Zhang X, Chen Y, Zha BS, et al. 2012. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br J Pharmacol. 165: 120-134.